Related Experiment Video
Updated: Feb 10, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
[Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer]
Yuming Wan1, Jing Huang2, Feng Xu1
1Lung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Abstract:
A few study has proven that about 90% of local control rates might be benefit from stereotactic body radiotherapy (SBRT) for patients with medically inoperable stage I non-small cell lung cancer (NSCLC), it is reported SBRT associated overall survival and tumor specific survival is comparable with those treated with surgery. SBRT has been accepted as the first line treatment for inoperable patients with peripheral located stage I NSCLC. However, the role of SBRT in centrally located lesions is controversial for potential toxic effects from the adjacent anatomical structure. This paper will review the definition, indication, dose regimens, dose-volume constraints for organs at risk, radiation technology, treatment side effect of centrally located NSCLC treated with SBRT and stereotactic body proton therapy.
Related Concept Videos
Lung Capacity
The Central Dogma
Measures of Central Tendency
Neurons: The Cell Body and the Dendrites
Location and Orientation of the Heart
Perceiving Loudness, Pitch, and Location
Place theory, or place coding, suggests that different pitches are heard because various sound waves activate specific locations along the cochlea's basilar membrane. The brain determines the pitch of a sound by...

